Evolution of Vitreomacular Traction Following the Use of the Dexamethasone Intravitreal Implant (Ozurdex) in the Treatment of Macular Edema Secondary to Central Retinal Vein Occlusion
Journal of Ocular Pharmacology and Therapeutics, 05/25/2012Bakri SJ et al.
A 71–year–old man who presented with macular edema secondary to central retinal vein occlusion was treated by intravitreal injections of bevacizumab followed by Ozurdex. Vitreomacular traction (VMT) developed during the course of treatment and became more evident when macular edema resolved after treatment with Ozurdex. VMT may become apparent and worsen after resolution of macular edema treated with intravitreal Ozurdex.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.